Literature DB >> 17674122

Plasmonic photothermal therapy (PPTT) using gold nanoparticles.

Xiaohua Huang1, Prashant K Jain, Ivan H El-Sayed, Mostafa A El-Sayed.   

Abstract

The use of lasers, over the past few decades, has emerged to be highly promising for cancer therapy modalities, most commonly the photothermal therapy method, which employs light absorbing dyes for achieving the photothermal damage of tumors, and the photodynamic therapy, which employs chemical photosensitizers that generate singlet oxygen that is capable of tumor destruction. However, recent advances in the field of nanoscience have seen the emergence of noble metal nanostructures with unique photophysical properties, well suited for applications in cancer phototherapy. Noble metal nanoparticles, on account of the phenomenon of surface plasmon resonance, possess strongly enhanced visible and near-infrared light absorption, several orders of magnitude more intense compared to conventional laser phototherapy agents. The use of plasmonic nanoparticles as highly enhanced photoabsorbing agents has thus introduced a much more selective and efficient cancer therapy strategy, viz. plasmonic photothermal therapy (PPTT). The synthetic tunability of the optothermal properties and the bio-targeting abilities of the plasmonic gold nanostructures make the PPTT method furthermore promising. In this review, we discuss the development of the PPTT method with special emphasis on the recent in vitro and in vivo success using gold nanospheres coupled with visible lasers and gold nanorods and silica-gold nanoshells coupled with near-infrared lasers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17674122     DOI: 10.1007/s10103-007-0470-x

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  89 in total

1.  The photodynamic properties of a particular hematoporphyrin derivative.

Authors:  R L LIPSON; E J BALDES
Journal:  Arch Dermatol       Date:  1960-10

2.  Photothermal sensitisation: evidence for the lack of oxygen effect on the photosensitising activity.

Authors:  Monica Camerin; Michael A J Rodgers; Malcolm E Kenney; Giulio Jori
Journal:  Photochem Photobiol Sci       Date:  2005-02-14       Impact factor: 3.982

3.  Immunotargeted nanoshells for integrated cancer imaging and therapy.

Authors:  Christopher Loo; Amanda Lowery; Naomi Halas; Jennifer West; Rebekah Drezek
Journal:  Nano Lett       Date:  2005-04       Impact factor: 11.189

Review 4.  Nanotechnology for the biologist.

Authors:  Scott E McNeil
Journal:  J Leukoc Biol       Date:  2005-05-27       Impact factor: 4.962

Review 5.  Interstitial laser hyperthermia in tumour therapy.

Authors:  A Masters; S G Bown
Journal:  Ann Chir Gynaecol       Date:  1990

Review 6.  Laser systems and their applications in medicine and biology.

Authors:  L Goldman; R J Rockwell
Journal:  Adv Biomed Eng Med Phys       Date:  1968

Review 7.  Phototherapy in tumors.

Authors:  S G Bown
Journal:  World J Surg       Date:  1983-11       Impact factor: 3.352

8.  Interstitial laser hyperthermia: a new approach to local destruction of tumours.

Authors:  A C Steger; W R Lees; K Walmsley; S G Bown
Journal:  BMJ       Date:  1989-08-05

9.  Melanosomes are a primary target of Q-switched ruby laser irradiation in guinea pig skin.

Authors:  L L Polla; R J Margolis; J S Dover; D Whitaker; G F Murphy; S L Jacques; R R Anderson
Journal:  J Invest Dermatol       Date:  1987-09       Impact factor: 8.551

10.  Microwave coagulation therapy for hepatocellular carcinoma.

Authors:  M Sato; Y Watanabe; S Ueda; S Iseki; Y Abe; N Sato; S Kimura; K Okubo; M Onji
Journal:  Gastroenterology       Date:  1996-05       Impact factor: 22.682

View more
  339 in total

1.  Comparison of oxidized porous silicon with bare porous silicon as a photothermal agent for cancer cell destruction based on in vitro cell test results.

Authors:  Chongmu Lee; Chanseok Hong; Jungkeun Lee; Mikwon Son; Soon-Sun Hong
Journal:  Lasers Med Sci       Date:  2011-12-08       Impact factor: 3.161

Review 2.  Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.

Authors:  Alicia Fernandez-Fernandez; Romila Manchanda; Anthony J McGoron
Journal:  Appl Biochem Biotechnol       Date:  2011-09-27       Impact factor: 2.926

3.  Laser nanothermolysis of human leukemia cells using functionalized plasmonic nanoparticles.

Authors:  Anton V Liopo; André Conjusteau; Marina Konopleva; Michael Andreeff; Alexander A Oraevsky
Journal:  Nano Biomed Eng       Date:  2012

4.  Effect of size, concentration, and type of spherical gold nanoparticles on heat evolution following laser irradiation using tissue-simulating phantoms.

Authors:  Hossam Zakaria; Wessameldin S Abdelaziz; Tareq Youssef
Journal:  Lasers Med Sci       Date:  2016-02-09       Impact factor: 3.161

5.  Design of Nanoparticle-Based Carriers for Targeted Drug Delivery.

Authors:  Xiaojiao Yu; Ian Trase; Muqing Ren; Kayla Duval; Xing Guo; Zi Chen
Journal:  J Nanomater       Date:  2016       Impact factor: 2.986

6.  Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications.

Authors:  Jonathan O Martinez; Brandon S Brown; Nicoletta Quattrocchi; Michael Evangelopoulos; Mauro Ferrari; Ennio Tasciotti
Journal:  Chin Sci Bull       Date:  2012-11-01

Review 7.  Phototriggered Drug Delivery Using Inorganic Nanomaterials.

Authors:  Qian Liu; Changyou Zhan; Daniel S Kohane
Journal:  Bioconjug Chem       Date:  2016-10-07       Impact factor: 4.774

Review 8.  Gold nanoparticles in breast cancer treatment: promise and potential pitfalls.

Authors:  Jihyoun Lee; Dev Kumar Chatterjee; Min Hyuk Lee; Sunil Krishnan
Journal:  Cancer Lett       Date:  2014-02-17       Impact factor: 8.679

Review 9.  Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.

Authors:  Shreya Goel; Christopher G England; Feng Chen; Weibo Cai
Journal:  Adv Drug Deliv Rev       Date:  2016-08-09       Impact factor: 15.470

10.  A drug-delivery vehicle combining the targeting and thermal ablation of HER2+ breast-cancer cells with triggered drug release.

Authors:  Jin-Oh You; Peng Guo; Debra T Auguste
Journal:  Angew Chem Int Ed Engl       Date:  2013-03-11       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.